Cell Biotech Co., Ltd. (KOSDAQ:049960)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Finished Product Business			48.60B	44.73B	40.35B	38.31B	39.76B
Finished Product Business Growth			8.66%	10.84%	5.32%	-3.64%	-28.37%
Raw Material Business Division			5.18B	5.80B	6.52B	7.27B	6.20B
Raw Material Business Division Growth			-10.58%	-11.10%	-10.29%	17.29%	-11.90%
Total			53.79B	50.53B	46.87B	45.58B	45.96B
Total Growth			6.46%	7.79%	2.83%	-0.82%	-26.52%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South Korea			27.85B	27.19B	29.68B	27.76B	26.14B
South Korea Growth			2.42%	-8.38%	6.91%	6.20%	-34.88%
Europe			15.93B	12.98B	9.41B	9.74B	8.78B
Europe Growth			22.75%	37.88%	-3.31%	10.86%	8.59%
Others			10.00B	10.35B	7.78B	8.09B	11.04B
Others Growth			-3.37%	33.06%	-3.77%	-26.75%	-22.90%
Total			53.79B	50.53B	46.87B	45.58B	45.96B
Total Growth			6.46%	7.79%	2.83%	-0.82%	-26.52%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 27, 2026

Data Sources Report a data error